Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension

(2021) Kelly M. Chin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension

(2020) Roberto Badagliacca et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Ralinepag Plasma Levels Correlate with Improvements in Functional and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension

(2019) H.W. Farber et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy Results from a Phase 2 randomized, parallel group, placebo-controlled trial

(2019) Fernando Torres et al.   EUROPEAN RESPIRATORY JOURNAL

Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension: A Double-Blind, Placebo-Controlled Study

(2019) R. James White et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension

(2018) Roberto Badagliacca et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Transition from parenteral to oral treprostinil in pulmonary arterial hypertension

(2017) Murali M. Chakinala et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension

(2013) Zhi-Cheng Jing et al.   CIRCULATION

Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonist

(2012) Brendan J. Whittle et al.   BIOCHEMICAL PHARMACOLOGY

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

(2012) Gérald Simonneau et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension

(2008) J.-W. Lankhaar et al.   EUROPEAN HEART JOURNAL